ASTRO Release: Doxepin Rinse Significantly Reduces Mouth Pain for Head and Neck Cancer Patients Who Receive Radiation Therapy  
10/29/2012 9:41:08 AM

BOSTON, Oct. 29, 2012 (GLOBE NEWSWIRE) -- When used as a rinse, doxepin, a tricyclic antidepressant, reduces oral mucositis (OM) in patients who receive radiation therapy (RT) for head and neck cancer, according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 54th Annual Meeting.